We will also had a special guest who is possibly the most successful corporate venture capitalist in health tech–Merck’s Bill Taranto. He had a decent run last decade– you may have heard of Livongo which he was a big investor in! We talked with Bill about the future of investing, what role investing in digital health has for drug business and what he’s expecting in the big health care realignment. Apparently Merck treasury took all the cash he made with Livongo so he couldn’t give it to us, but he has $500m+ top spend and as he said, “you want a Billion Dollar exit? Put me on the board”
You can see the video below live and the audio will be on our podcast channel (Apple/Spotify) from Friday
There was almost nothing to talk about. No inauguration, no riots, pandemic under control via vaccination….oh wait. Actually a lot to talk about with the vaccination rollout, the likelihood of health policy changing in the COVID relief bill, and how the wild world of Gamestop stock trading might impact Digital Health –well we didn’t talk about that but we did talk about employers and what they were going to do!
The video is below but if you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels.
With the long-awaited inauguration day behind us, America is finally getting something we desperately need: an elected woman in the White House.
On the heels of chaos and violence at the Capitol and after four years of the Trump Administration, we are ready for strong female leadership in the executive branch to help put the country on the right course. In fact, it is long overdue.
Kamala Harris didn’t just need our votes to make history as America’s first female Vice President. To be successful, she’ll need every ounce of our ongoing support as she steels herself to direct threats to her life and faces the challenge, along with President-elect Biden, of healing a deeply fractured nation.
Female leaders around the world have modeled that strong leadership through 2020’s most difficult times. Women have led some of the most effective pandemic responses worldwide. Countries led by women leaders had six times fewer confirmed COVID-19 deaths — and fewer days with confirmed deaths — than countries led by men. New Zealand, Taiwan, Germany, and Iceland — all led by women — are among the coronavirus management success stories.
These women acknowledged the threat from coronavirus rather than underplaying it. They were decisive, and used data and science to drive their decision-making. They took a long-view when designing their response, prioritizing long-term well-being over short-term economic pain. They listened to outside voices to ensure they had the best possible input and solutions for their countries. And they showed empathy. Having a female leader became a symbol of inclusive, open-minded, effective leadership.
And the world took notice, lauding leaders like Jacinda Ardern, who was rewarded with a decisive victory in New Zealand’s October national elections.
Rosemarie Day has been a long time health care consultant and operator, most prominently as the COO of the Massachusetts Health Connector–the first real state exchange that was created as part of Romneycare (which with a few twists later became Obamacare!) Following the 2017 Women’s March, Rosemarie decided to write her own book, Marching Towards Coverage. It’s really four books in one. A personal patient & caregiver journal; a history of the slow march towards universal health care; a policy document; and a primer on how to become an activist. All in less than 200 pages! For the November THCB Book Club Jessica DaMassa and Matthew Holt talked with Rosemarie about what we can all do to really get to better health care for everyone.
Episode 33 of “The THCB Gang” was live-streamed here Thursday, November 19th. You can watch it below.
Matthew Holt (@boltyboy) was joined by some of our regulars: CEO of Day Health Strategies Rosemarie Day (@Rosemarie_Day1), data privacy expert Deven McGraw (@healthprivacy), patient safety expert Michael Millenson (@MLMillenson) and health futurist Ian Morrison (@seccurve). While the chaos of the post election legal shenanigans goes on, we chatted what the Biden team might and can do, and look at the pre- and post-vaccine COVID-19 future of health care.
If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels.
Episode 30 of “The THCB Gang” was live-streamed on Thursday, November 5th. Watch it below!
Matthew Holt (@boltyboy) was joined by regulars, CEO of Day Health Strategies Rosemarie Day (@Rosemarie_Day1), medical historian & health economist Mike Magee MD (@drmikemagee), fierce patient activist Casey Quinlan (@MightyCasey), writer Kim Bellard (@kimbbellard), and patient & entrepreneur Robin Farmanfarmaian (@Robinff3). The conversation revolved around the underlying value structures in America, what a Republican Senate looks like for the ACA, and how will the (at the time likely but not certain) Democratic Administration change the narrative around health policy.
If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan
One of the most important responsibilities of the American government is to protect its citizens from harmful industry practices, from lead poisoning to dangerous pharmaceuticals to financial meltdowns. Its record is far from perfect, but government regulators usually act in good faith and in turn earn the trust of those they protect. As we head into Tuesday’s election, it’s important to shine a spotlight on the fact that the Trump administration has betrayed that trust yet again. They have allowed low-quality, unregulated forms of insurance called Short-Term Limited Duration Insurance (STLDI) to prey upon those who lost their jobs during this pandemic. Also known as “junk” insurance, this issue has gotten far less attention than the need to protect people with pre-existing conditions. But the consequences of its inadequate coverage can be just as devastating.
Only 57% of STLDI plans cover mental health care, only 29% cover prescription drugs, and virtually none cover pregnancy. These plans are also allowed to discriminate against the sick, which most do in order to save money. STLDI managed to penetrate the market through a combination of cheap prices, lucrative broker incentives, and deceptive marketing.
Consumers get very little back for their money with these plans. Plans on the Affordable Care Act’s exchanges must spend 80 cents out of every premium dollar collected on care. In 2018, the top five STLDI insurers spent only 43 cents.
Originally envisioned as short-term solutions to gaps caused by unexpected coverage loss, the Trump administration extended their maximum length from three to 12 months and allowed renewals that can essentially extend them to three years, thus drawing consumers away from the individual markets established under Obamacare. This was essentially a kick in the gut for the law, after the current administration was unable to win any legislative or court battles against it.
Episode 28 of “The THCB Gang” was live-streamed on Thursday, October 15th! Watch it below!
Matthew Holt (@boltyboy) was joined by some of our regulars: communications leader Jennifer Benz (@jenbenz), data privacy expert Deven McGraw (@healthprivacy), CEO of addiction recovery service Suntra Modern Recovery, Jean-Luc Neptune MD (@jeanlucneptune), CEO of Day Health Strategies Rosemarie Day (@Rosemarie_Day1), medical historian & health economist Mike Magee MD (@drmikemagee), policy & tech expert Vince Kuraitis (@VinceKuraitis). The conversation focused on the looming election, the new COVID-19 Surge, Amy Coney Barrett’s hearing, and health care costs rising in the US costs.
If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan,producer